Maartje I. Kester - Concepedia

Author

Maartje I. Kester

Amsterdam UMC Location Vrije Universiteit Amsterdam

Also Known As

K. Jellema, M. I. Kester, M.I. Kester, Maartje I Kester, Maartje I. Kester, Maartje Kester

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam Amsterdam Neuroscience Amsterdam University Medical Centers Vrije Universiteit Amsterdam HAN University of Applied Sciences

About

Maartje I. Kester is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, alzheimer's disease, and dementia.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	285
2	Health Sciences	3	3	57
3	Public Health	2	2	59
4	Clinical Nutrition	1	1	19
5	Geriatrics	1	1	40

Maartje I. Kester

Publications

Citations

H-Index

Page 1

	Year	Citations
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort Niki S.M. Schoonenboom, Fransje E. Reesink, Nicolaas A. Verwey, Neurology	2011	302
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease Maartje I. Kester, Charlotte E. Teunissen, Daniel L. Crimmins, JAMA Neurology	2015	250
Patients With Alzheimer Disease With Multiple Microbleeds Jeroen D.C. Goos, Maartje I. Kester, Frederik Barkhof, Stroke	2009	213
CSF biomarkers predict rate of cognitive decline in Alzheimer disease Maartje I. Kester, Annelies E. van der Vlies, Marinus A. Blankenstein, Neurology	2009	163
Associations Between Cerebral Small-Vessel Disease and Alzheimer Disease Pathology as Measured by Cerebrospinal Fluid Biomarkers Maartje I. Kester, Jeroen D.C. Goos, Charlotte E. Teunissen, JAMA Neurology	2014	162
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer’s disease in a memory clinic cohort Maartje I. Kester, Charlotte E. Teunissen, Courtney L. Sutphen, Alzheimer s Research & Therapy	2015	135
Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer’s Disease in Non-Demented Elderly Rosalinde E.R. Slot, Argonde C. van Harten, Maartje I. Kester, Journal of Alzheimer s Disease	2016	87
Standardization of Assay Procedures for Analysis of the CSF Biomarkers Amyloid<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn mathvariant="bold">1</mml:mn><mml:mtext>-</mml:mtext><mml:mn mathvariant="bold">42</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msub></mml:mrow></mml:math>, Tau, and Phosphorylated Tau in Alzheimer's Disease: Report of an International Workshop Charlotte E. Teunissen, Niek A. Verwey, Maartje I. Kester, International Journal of Alzheimer s Disease Mn Mathvariant=PathologyNeurochemical BiomarkersPtau AssaysAssay Procedures	2010	70
Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers Maartje I. Kester, P Scheffer, Marleen J.A. Koel‐Simmelink, Neurobiology of Aging	2011	62
Amyloid-β Oligomers Relate to Cognitive Decline in Alzheimer's Disease Wesley Jongbloed, Kim Bruggink, Maartje I. Kester, Journal of Alzheimer s Disease	2015	61

Page 1